Skip to main content
Field Trip Health Logo Field Trip Health Logo
  • Home
    • About
      • Field Trip Health
      • Field Trip Discovery
      • Field Trip Digital
    • News
      • Press Releases
      • Events and Presentations
      • In the Media
    • Stock Information
      • CSE
      • OTC
    • Financials
      • SEDAR Filings
    • Governance
      • Board & Advisors
      • Management Team
      • Governance Documents
      • Whistleblower Portal
    • Contact Us
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts

Site Search

In the Media

  • Home
    • About
      • Field Trip Health
      • Field Trip Discovery
      • Field Trip Digital
    • News
      • Press Releases
      • Events and Presentations
      • In the Media
    • Stock Information
      • CSE
      • OTC
    • Financials
      • SEDAR Filings
    • Governance
      • Board & Advisors
      • Management Team
      • Governance Documents
      • Whistleblower Portal
    • Contact Us
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
Download item year list 2020
Date Download Description
November 9, 2020
Lucid News: New Program Brings Ketamine-Assisted Psychotherapy to Canadian Vets (opens in new window)
October 7, 2020
Forbes: Psychedelic Therapy Company, Field Trip Health, Goes Public to Revolutionize Mental Health Treatments (opens in new window)
October 6, 2020
Canadian Securities Exchange: Field Trip Health (CSE:FTRP) Opens the Stock Market | Canadian Securities Exchange (opens in new window)
October 6, 2020
Benzinga: Field Trip Health Begins Trading On CSE (opens in new window)
October 5, 2020
Psychedelic Stock Watch: Field Trip RTO Provides Exciting New Investing Option (opens in new window)
October 2, 2020
Business Insider: Field Trip Health Ltd. Completes Reverse Takeover Transaction and Prepares for Listing on CSE (opens in new window)
September 29, 2020
Psilocybin Alpha: Field Trip Announces Successful GLP Synthesis Results from Initial Preclinical Testing for FT-104, Its First Molecule in Development (opens in new window)
September 29, 2020
Biotuesdays: Field Trip Completes GLP Synthesis of FT-104 (opens in new window)

Read More

Contact Us

We'd love to hear from you

investors@fieldtriphealth.com

Quick Links

  • Investor FAQs
  • Information Request Form

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Field Trip Health Ltd., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Field Trip Health Ltd. to send you the requested Investor Email Alert updates.

* Required

*
*




Unsubscribe

Email Alert Sign Up Confirmation

Field Trip Health Logo
© Field Trip Health Ltd. All Rights Reserved.
  • Patient Privacy Policy
  • Notice of Privacy Practices
  • Electronic Consent Policy
  • follow us on instagram
  • follow us on facebook
  • follow us on linkedin
  • follow us on twitter
Powered By Q4 Inc. 5.52.0.6 (opens in new window)
SUBSCRIBE TO OUR EMAIL LIST